Ampyzine

Ampyzine
Clinical data
Other names	Dimethylaminopyrazine; W-3580B; W3580-B; W-3580-B; W3580B
ATC code	none;
Identifiers
	IUPAC name N,N-Dimethylpyrazin-2-amine;
CAS Number	5214-29-9 ;
PubChem CID	199885;
ChemSpider	21955 ;
UNII	630GTK993N;
ChEMBL	ChEMBL2110770 ;
CompTox Dashboard (EPA)	DTXSID70200136 ;
Chemical and physical data
Formula	C6H9N3
Molar mass	123.159 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES n1ccnc(N(C)C)c1;
	InChI InChI=1S/C6H9N3/c1-9(2)6-5-7-3-4-8-6/h3-5H,1-2H3 ; Key:UUINNXPPLPDRQX-UHFFFAOYSA-N ;

Ampyzine (INNTooltip International Nonproprietary Name), also known as dimethylaminopyrazine or as ampyzine sulfate (USANTooltip United States Adopted Name) in the case of the sulfate salt (developmental code name W-3580B), is a drug described as a "central stimulant" or "CNS stimulant" and "euphoriant". It is said to be a monoamine oxidase inhibitor (MAOI). Ampyzine was first described in the scientific literature by 1960.

An analogue of ampyzine is triampyzine (3,5,6-trimethylampyzine; developmental code name W-3976B). This drug is described as an anticholinergic and antisecretory agent.